Literature DB >> 27746645

Case of Pleomorphic Dermal Sarcoma of the Eyelid Treated with Micrographic Surgery and Secondary Intention Healing.

Jung-In Kim1, Young-Jun Choi1, Hyun-Min Seo2, Han-Saem Kim1, Jae Yun Lim1, Dong-Hoon Kim3, Seoung Wan Chae3, Ga-Young Lee1, Won-Serk Kim1.   

Abstract

Pleomorphic dermal sarcoma (PDS) is a rare mesenchymal neoplasm sharing histopathological features with atypical fibroxanthoma (AFX), but has additional features of deep invasion of the superficial subcutis, tumor necrosis and vascular/perineural invasion. It is not well documented in the literature because of its rarity, and its clinical course has been debated due to the lack of homogenous criteria. We describe here the case of a 91-year-old female with a 6-month history of a solitary, asymptomatic, well-defined, 3.4-cm-sized, reddish, hard, protruding mass on the lateral aspect of the right upper eyelid. On the basis of initial punch biopsy results, storiform cellular infiltrate of pleomorphic spindle and polygonal cells with frequent atypical mitoses, the lesion was identified as AFX. Following the initial biopsy, micrographic surgery was performed and a tumor-free margin was confirmed. Considering the conservation of the periocular function and the advanced age of the patient, we planned secondary intention healing rather than primary suturing. After surgery, skeletal muscle infiltration was found and the diagnosis was revised to PDS by a pathologist based on the currently accepted criteria for PDS. There has been no evidence of recurrence or periocular functional defects during a 2-year follow-up without adjuvant therapy. Although the PDS is highly malignant, complete excision under micrographic surgery can prevent recurrence without adjuvant therapy. Also, the secondary intention healing is an effective method for closure of large defects on the face.

Entities:  

Keywords:  Atypical fibroxanthoma; Histiocytic sarcoma; Malignant fibrous histiocytoma; Pleomorphic dermal sarcoma; Undifferentiated pleomorphic sarcoma

Year:  2016        PMID: 27746645      PMCID: PMC5064195          DOI: 10.5021/ad.2016.28.5.632

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  15 in total

1.  Correction and clarification regarding AFX and pleomorphic dermal sarcoma.

Authors:  Timothy H McCalmont
Journal:  J Cutan Pathol       Date:  2012-01       Impact factor: 1.587

2.  Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.

Authors:  Maria Delia Perez-Montiel; Jose Antonio Plaza; Hugo Dominguez-Malagon; Saul Suster
Journal:  Am J Dermatopathol       Date:  2006-04       Impact factor: 1.533

3.  Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases.

Authors:  Trevor W Beer; Paul Drury; Peter J Heenan
Journal:  Am J Dermatopathol       Date:  2010-08       Impact factor: 1.533

4.  Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis.

Authors:  C Merck; L Angervall; L G Kindblom; A Odén
Journal:  Acta Pathol Microbiol Immunol Scand Suppl       Date:  1983

5.  Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".

Authors:  Stefan Kraft; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

6.  Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.

Authors:  Nicholas Harding-Jackson; Martin Sangueza; Alexander Mackinnon; Saul Suster; Jose A Plaza
Journal:  Am J Dermatopathol       Date:  2015-07       Impact factor: 1.533

7.  More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?

Authors:  Gina C Ang; Randall K Roenigk; Clark C Otley; P Kim Phillips; Amy L Weaver
Journal:  Dermatol Surg       Date:  2008-03-23       Impact factor: 3.398

8.  Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms.

Authors:  Atiya Mansoor; Clifton R White
Journal:  Am J Dermatopathol       Date:  2003-08       Impact factor: 1.533

Review 9.  The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification.

Authors:  Christopher D M Fletcher
Journal:  Histopathology       Date:  2013-10-25       Impact factor: 5.087

10.  TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.

Authors:  Klaus G Griewank; Bastian Schilling; Rajmohan Murali; Nicola Bielefeld; Marion Schwamborn; Antje Sucker; Lisa Zimmer; Uwe Hillen; Jörg Schaller; Thomas Brenn; Dirk Schadendorf; Thomas Mentzel
Journal:  Mod Pathol       Date:  2013-09-13       Impact factor: 7.842

View more
  2 in total

1.  Pleomorphic Dermal Sarcoma of the Scalp.

Authors:  Nikolai Klebanov; Mai P Hoang; Bobby Y Reddy
Journal:  Cureus       Date:  2018-07-13

2.  Undifferentiated pleomorphic sarcoma.

Authors:  Ana Carolina Gonçalves de Paiva; Marilda Aparecida Milanez Morgado de Abreu; Marcela Pesce de Souza
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.